![Connie Matsui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Connie Matsui
Ordförande på
ARTELO BIOSCIENCES, INC.
Förmögenhet: 146 444 $ per 2026-05-31
Profil
Connie L.
Matsui is currently Chairman at Sutro Biopharma, Inc. since 2019 and Chairman at Artelo Biosciences, Inc. since 2017.
Former roles include President & Chief Executive Officer at The San Diego Foundation from 2018 to 2019; Chairman-Collaboration & Senior Vice President at IDEC Pharmaceuticals Corp.
from 1992 to 2004; Chairman & President at Girl Scouts of the USA from 1999 to 2002; Chairman at Balboa Park Conservancy; Independent Director at Halozyme Therapeutics, Inc. from 2011 to 2016; Executive Vice President-Knowledge & Innovation Networks at Biogen, Inc. from 2004 to 2009; Executive Vice President at Biogen Idec New Ventures, Inc. from 1992 to 2008; and EVP-Knowledge & Innovation Networks at Biogen Idec, Inc. (North Carolina) from 2004 to 2009.
Education includes an undergraduate degree conferred in 1975 and an MBA conferred in 1977, both from Stanford University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SUTRO BIOPHARMA, INC. 0,03 % | 2026-06-05 | 5 000 ( 0,03 % ) | 146 150 $ | 2026-05-31 |
ARTELO BIOSCIENCES INC 0,01 % | 2026-02-20 | 210 ( 0,01 % ) | 294 $ | 2026-05-31 |
Aktiva positioner av Connie Matsui
| Företag | Position | Start |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Ordförande | 2017-05-02 |
| SUTRO BIOPHARMA, INC. | Ordförande | 2019-06-24 |
Tidigare kända positioner av Connie Matsui
| Företag | Position | Slut |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Ordförande | - |
The San Diego Foundation
 The San Diego Foundation Miscellaneous Commercial ServicesCommercial Services Provides information about charitable giving and community needs | Verkställande Direktör | 2019-05-01 |
| BIOGEN INC. | Företagsledare/Principal | 2009-01-01 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Företagsledare/Principal | 2009-01-01 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Företagsledare/Principal | 2008-03-31 |
Connie Matsuis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
73
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
The San Diego Foundation
The San Diego Foundation Miscellaneous Commercial ServicesCommercial Services Provides information about charitable giving and community needs | Commercial Services |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Girl Scouts of the USA
 Girl Scouts of the USA Miscellaneous Commercial ServicesCommercial Services Helps to build character and skills for girls | Commercial Services |
Balboa Park Conservancy
 Balboa Park Conservancy Miscellaneous Commercial ServicesCommercial Services Provides advocacy services | Commercial Services |
